SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
FS KKR Capital Corp. (FSK) trades at a trailing P/E of 256.8, forward P/E of 6.3. Trailing earnings yield is 0.39%, forward earnings yield 15.92%. Graham Number is $4.30.
Criteria proven by this page:
- VALUE (62/100, Pass) — analyst target implies upside (+53.8%).
- Forward P/E 6.3 (down from trailing 256.8) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 0.39% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 15.92% as earnings recover.
- Analyst consensus target $16.50 (+53.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — FSK
Valuation Multiples
P/E (TTM)256.8
Forward P/E6.3
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.48
P/S Ratio3.84
EV/EBITDA44.3
Per Share Data
EPS (TTM)$0.04
Forward EPS (Est.)$1.71
Book Value / Share$20.88
Revenue / Share$2.63
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.39%
Forward Earnings Yield15.92%
Dividend Yield25.58%
Graham Number$4.30
SharesGrow IV$26.90 (+150.7%)
Analyst Target$16.50 (+53.8%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
8.5 |
0.01 |
1.09 |
6.48 |
8.65% |
| 2017 |
9.9 |
-0.26 |
0.79 |
6.58 |
12.09% |
| 2018 |
2.3 |
0.01 |
0.31 |
1.95 |
15.90% |
| 2019 |
12.9 |
-0.16 |
0.82 |
7.18 |
10.75% |
| 2020 |
-5.1 |
0.02 |
0.66 |
-10.14 |
16.52% |
| 2021 |
2.9 |
-0.01 |
0.57 |
2.51 |
11.33% |
| 2022 |
53.9 |
-0.56 |
0.71 |
10.72 |
14.87% |
| 2023 |
8.0 |
0.01 |
0.82 |
4.55 |
14.70% |
| 2024 |
10.4 |
-0.66 |
0.92 |
5.48 |
16.57% |
| 2025 |
377.1 |
-3.84 |
0.71 |
3.54 |
18.90% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.84 |
$387M |
$294M |
76% |
| 2017 |
$2.96 |
$276.52M |
$182M |
65.8% |
| 2018 |
$9.05 |
$394M |
$569M |
144.4% |
| 2019 |
$1.90 |
$443M |
$246M |
55.5% |
| 2020 |
$-3.26 |
$149M |
$-405M |
-271.8% |
| 2021 |
$7.16 |
$1.54B |
$1.52B |
98.2% |
| 2022 |
$0.32 |
$1.64B |
$92M |
5.6% |
| 2023 |
$2.48 |
$1.23B |
$696M |
56.6% |
| 2024 |
$2.09 |
$1.11B |
$585M |
52.7% |
| 2025 |
$0.04 |
$1.17B |
$11M |
0.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.71 |
$1.64 – $1.79 |
$1.25B |
$1.24B – $1.26B |
8 |
| 2027 |
$1.64 |
$1.50 – $1.77 |
$1.21B |
$1.16B – $1.25B |
8 |
| 2028 |
$1.60 |
$1.51 – $1.71 |
$1.08B |
$1.08B – $1.08B |
1 |
